Survival RateCell SurvivalSurvival AnalysisDisease-Free SurvivalRetrospective StudiesTreatment OutcomeSurvivalPrognosisGraft SurvivalFollow-Up StudiesTime FactorsNeoplasm StagingKaplan-Meier EstimateCombined Modality TherapyDelayed DiagnosisProportional Hazards ModelsNeoplasm Recurrence, LocalAntineoplastic Combined Chemotherapy ProtocolsPrenatal DiagnosisEarly DiagnosisSensitivity and SpecificityProspective StudiesRisk FactorsLung NeoplasmsMultivariate AnalysisLiver NeoplasmsAdenocarcinomaPredictive Value of TestsTumor Markers, BiologicalAge FactorsCohort StudiesBreast NeoplasmsLymphatic MetastasisImmunohistochemistryDiagnosisRegistriesRecurrenceActuarial AnalysisChemotherapy, AdjuvantDisease ProgressionAntineoplastic AgentsTomography, X-Ray ComputedCarcinoma, Squamous CellCarcinoma, HepatocellularLiver TransplantationNeoplasm MetastasisPostoperative ComplicationsIncidenceInfant, NewbornCisplatinRisk AssessmentApoptosisBiopsyStomach NeoplasmsBrain NeoplasmsPancreatic NeoplasmsNeoplasmsRadiotherapy, AdjuvantHepatectomyPregnancyVincristineCarcinoma, Non-Small-Cell LungReoperationCyclophosphamideCarcinomaDoxorubicinNeoplasm InvasivenessColorectal NeoplasmsKidney TransplantationDiagnostic ErrorsReproducibility of ResultsRemission InductionEsophageal NeoplasmsUnited StatesFluorouracilCell Line, TumorSeverity of Illness IndexDrug Administration ScheduleGraft RejectionLife TablesRadiotherapy DosageBone NeoplasmsChi-Square DistributionPolymerase Chain ReactionAcute DiseaseLymph Node ExcisionBile Duct NeoplasmsSEER ProgramPrednisoneMagnetic Resonance ImagingBiopsy, NeedleMutationSarcomaJapanSignal TransductionGastrectomyDiagnosis, Computer-AssistedSex FactorsMelanomaNursing Diagnosis